The molecular-level changes in early heart disease occur on the nanoscale. To detect these changes, we are building nanoscale robots, smaller than cells, that will navigate the body. This will enable us to see inside even the narrowest blood vessels, to detect the fatty deposits (atherosclerotic plaque) that signal the start of arterial blockage and allow treatment before the disease progresses.